Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Metadata
Title
Current concepts in treatment of childhood acute lymphoblastic leukemia
Author
Ching-Hon Pui
Publication date
01-03-2002
Publisher
Springer-Verlag
Published in
International Journal of Hematology / Issue Special Issue 2/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF03165130

Other articles of this Special Issue 2/2002

International Journal of Hematology 2/2002 Go to the issue

Update on Hypercoagulability

Recent advances in the diagnosis of antiphospholipid syndrome

Current Concepts of the Myeloproliferative Diseases

Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV

The Biology and Treatment of Acute Myeloid Leukemia

New advances in the treatment of acute promyelocytic leukemia

Non-malignant Hematologic Disorders in Childhood

An approach to the diagnosis and treatment of bleeding disorders in infants

Hematomorphology

The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of chronic myeloproliferative diseases

Histocompatibility in Field of Hematology

Current and emerging technology for HLA typing
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits